98%
921
2 minutes
20
Postgraduate programs (PGPs) in pharmacy practice have gained significant importance in recent years, reflecting the evolving roles and expanding responsibilities of pharmacists globally. Understanding the factors that influence the decision to pursue such programs is essential for workforce development and educational planning. This study aimed to assess the motivations and barriers influencing pharmacy interns in Saudi Arabia to pursue PGPs in pharmacy practice. This cross-sectional study was conducted from December 2019 to March 2020 and utilized a validated questionnaire distributed electronically to pharmacy interns (sixth-year pharmacy students) across 3 major pharmacy schools in Saudi Arabia. Data were analyzed using descriptive statistics, chi-square, and Fisher's exact tests, with a significance level set at a -value of less than .05. Of the 247 pharmacy interns invited, 157 (62%) completed the survey. Most respondents were female (82.8%) and had an average of 3 clinical and 2 nonclinical advanced pharmacy practice experiences. Approximately 20% intended to pursue PGPs immediately after graduation, while 60% would consider them later. Preferred career paths included hospital pharmacy (31.85%) and regulatory bodies (24.84%). The decision to pursue PGPs in pharmacy practice was influenced by PGP orientation during school, either positively or negatively. The primary motivator cited was the need for further training for future positions, whereas high competition was the most significant barrier. These findings offer valuable insight into pharmacy interns' perspectives on PGPs, highlighting key motivators and barriers. This understanding can inform future educational strategies and stakeholder efforts aimed at supporting pharmacy interns' career planning and addressing workforce development needs in pharmacy practice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12334812 | PMC |
http://dx.doi.org/10.1177/00469580251361346 | DOI Listing |
Diabetologia
September 2025
Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
This review article, developed by the EASD Global Council, addresses the growing global challenges in diabetes research and care, highlighting the rising prevalence of diabetes, the increasing complexity of its management and the need for a coordinated international response. With regard to research, disparities in funding and infrastructure between high-income countries and low- and middle-income countries (LMICs) are discussed. The under-representation of LMIC populations in clinical trials, challenges in conducting large-scale research projects, and the ethical and legal complexities of artificial intelligence integration are also considered as specific issues.
View Article and Find Full Text PDFBasic Clin Pharmacol Toxicol
October 2025
HUS Pharmacy, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist-led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's primary care health centres. To explore pharmacists' and physicians' insights, qualitative semi-structured interviews were conducted via Microsoft Teams with physicians and pharmacists involved in a pharmacist-led deprescribing.
View Article and Find Full Text PDFCutan Ocul Toxicol
September 2025
Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Kamrup, Assam, India.
Objective: This study aimed to assess the potential risk of Bullous pemphigoid (BP) associated with antidiabetic agents, antimicrobials, diuretics, immune checkpoint inhibitors, and biological agents.
Research Design And Methods: A retrospective pharmacovigilance data analysis was conducted using the FDA Adverse Event Reporting System (FAERS) between Q1/2004 and Q3/2024. Disproportionality analyses, viz.
Can Vet J
September 2025
Amy Noonan is an Economic Analyst at the Ontario Veterinary Medical Association. Having been deeply entrenched in the industry with veterinarian parents, her background in marketing and finance offers veterinarians actionable insights to optimize their practice.
Antimicrob Steward Healthc Epidemiol
September 2025
Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.